Cuiling Qi

1.6k total citations
44 papers, 1.1k citations indexed

About

Cuiling Qi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cuiling Qi has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Cuiling Qi's work include Angiogenesis and VEGF in Cancer (14 papers), Axon Guidance and Neuronal Signaling (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Cuiling Qi is often cited by papers focused on Angiogenesis and VEGF in Cancer (14 papers), Axon Guidance and Neuronal Signaling (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Cuiling Qi collaborates with scholars based in China, United States and Australia. Cuiling Qi's co-authors include Jiangchao Li, Bo Wei, Lijing Wang, Qianqian Zhang, Lijing Wang, Yang Yang, Lingyun Zheng, Tian Lan, Xiaodong He and Hongbo Wei and has published in prestigious journals such as PLoS ONE, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Cuiling Qi

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuiling Qi China 19 545 346 296 163 134 44 1.1k
Sun Young Yoon South Korea 18 816 1.5× 319 0.9× 295 1.0× 154 0.9× 162 1.2× 56 1.3k
Yongqian Shu China 18 470 0.9× 403 1.2× 210 0.7× 175 1.1× 274 2.0× 42 1.1k
Dongxian Guan China 14 503 0.9× 255 0.7× 250 0.8× 154 0.9× 67 0.5× 17 891
Tadashi Uwagawa Japan 17 521 1.0× 482 1.4× 363 1.2× 244 1.5× 127 0.9× 42 1.2k
Zhigang Peng China 19 468 0.9× 165 0.5× 274 0.9× 77 0.5× 118 0.9× 68 862
Xiaodong Xu China 18 645 1.2× 273 0.8× 260 0.9× 214 1.3× 157 1.2× 59 1.2k
Azhar R. Hussain Saudi Arabia 18 522 1.0× 280 0.8× 269 0.9× 88 0.5× 72 0.5× 37 989
Călin Ionescu Romania 14 814 1.5× 265 0.8× 447 1.5× 114 0.7× 126 0.9× 20 1.3k
Lei Bi China 17 543 1.0× 218 0.6× 215 0.7× 95 0.6× 123 0.9× 46 977
Xiaojing Cheng China 19 690 1.3× 352 1.0× 312 1.1× 179 1.1× 211 1.6× 57 1.3k

Countries citing papers authored by Cuiling Qi

Since Specialization
Citations

This map shows the geographic impact of Cuiling Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuiling Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuiling Qi more than expected).

Fields of papers citing papers by Cuiling Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuiling Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuiling Qi. The network helps show where Cuiling Qi may publish in the future.

Co-authorship network of co-authors of Cuiling Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Cuiling Qi. A scholar is included among the top collaborators of Cuiling Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuiling Qi. Cuiling Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qiao, Na Ye, Yuying Yao, et al.. (2024). EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167114–167114. 3 indexed citations
2.
Liu, Qiao, Jian Chen, Yi Ding, et al.. (2023). CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. BMC Cancer. 23(1). 6 indexed citations
3.
Li, Jinlian, Yuanyuan Li, Yongxia Yang, et al.. (2022). Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2. Frontiers in Pharmacology. 12. 804265–804265. 5 indexed citations
4.
Liu, Ying, Cuiling Qi, Lingyun Zheng, et al.. (2021). 1H-NMR based metabolic study of MMTV-PyMT mice along with pathological progress to screen biomarkers for the early diagnosis of breast cancer. Molecular Omics. 18(2). 167–177. 1 indexed citations
5.
Li, Junchen, Yi Ding, Yuying Yao, et al.. (2021). Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway. Frontiers in Cell and Developmental Biology. 9. 643525–643525. 31 indexed citations
6.
Li, Li, Shuhua Deng, Jiayuan Chen, et al.. (2020). Slit2/Robo1 Mitigates DSS-induced Ulcerative Colitis by Activating Autophagy in Intestinal Stem Cell. International Journal of Biological Sciences. 16(11). 1876–1887. 25 indexed citations
7.
Li, Qianming, Y. He, Xiaohua Liu, et al.. (2019). R5, a neutralizing antibody to Robo1, suppresses breast cancer growth and metastasis by inhibiting angiogenesis via down-regulating filamin A. Experimental Cell Research. 387(1). 111756–111756. 11 indexed citations
8.
He, Y., et al.. (2018). Generation and Biological Characteristics of a Mouse Model of Breast Cancer that Copresents with Diabetes Mellitus. The Anatomical Record. 302(2). 269–277. 3 indexed citations
9.
Zhang, Qianqian, Jian Chen, Da‐Lei Zhou, et al.. (2017). Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer. International Journal of Biological Sciences. 13(4). 471–479. 11 indexed citations
10.
Qi, Cuiling, Bin Li, Yang Yang, et al.. (2016). Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis. Scientific Reports. 6(1). 27819–27819. 25 indexed citations
11.
Zhang, Qianqian, Xiwen Hu, Yilong Liu, et al.. (2015). CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment. Scientific Reports. 5(1). 15948–15948. 47 indexed citations
12.
Qi, Cuiling, Bo Wei, Weijie Zhou, et al.. (2015). P-selectin-mediated platelet adhesion promotes tumor growth. Oncotarget. 6(9). 6584–6596. 71 indexed citations
13.
Wang, Hongyan, Xiaoying Guan, Yong-Sheng Tu, et al.. (2015). MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. Journal of Experimental & Clinical Cancer Research. 34(1). 59–59. 68 indexed citations
14.
Lan, Tian, Changzheng Li, Lingyun Zheng, et al.. (2015). Activation of Slit2-Robo1 signaling promotes liver fibrosis. Journal of Hepatology. 63(6). 1413–1420. 75 indexed citations
15.
Li, Jiangchao, Hong Yang, Yan Li, et al.. (2014). microRNA-146 up-regulation predicts the prognosis of non-small cell lung cancer by miRNA in situ hybridization. Experimental and Molecular Pathology. 96(2). 195–199. 36 indexed citations
16.
Zhang, Qianqian, Da‐Lei Zhou, Yi Ding, et al.. (2014). Andrographolide inhibits melanoma tumor growth by inactivating the TLR4/NF-κB signaling pathway. Melanoma Research. 24(6). 545–555. 34 indexed citations
17.
Qi, Cuiling, Jie Ye, Weidong Li, et al.. (2014). Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis. Laboratory Investigation. 94(7). 766–776. 17 indexed citations
18.
Qi, Cuiling, Bo Wei, Jie Ye, et al.. (2014). P-Selectin-Mediated Platelet Adhesion Promotes the Metastasis of Murine Melanoma Cells. PLoS ONE. 9(3). e91320–e91320. 38 indexed citations
19.
Zheng, Lingyun, Cuiling Zeng, Teng Wu, et al.. (2014). Inactivation of PI3Kδ Induces Vascular Injury and Promotes Aneurysm Development by Upregulating the AP-1/MMP-12 Pathway in Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 35(2). 368–377. 16 indexed citations
20.
Wei, Bo, Xiaoyan Han, Cuiling Qi, et al.. (2012). Coaction of Spheroid-Derived Stem-Like Cells and Endothelial Progenitor Cells Promotes Development of Colon Cancer. PLoS ONE. 7(6). e39069–e39069. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Young Yoon Breakdown of academic impact, for papers by Yongqian Shu Breakdown of academic impact, for papers by Dongxian Guan Breakdown of academic impact, for papers by Tadashi Uwagawa Breakdown of academic impact, for papers by Zhigang Peng Breakdown of academic impact, for papers by Xiaodong Xu Breakdown of academic impact, for papers by Azhar R. Hussain Breakdown of academic impact, for papers by Călin Ionescu Breakdown of academic impact, for papers by Lei Bi Breakdown of academic impact, for papers by Xiaojing Cheng
Rankless by CCL
2026